GlassScriptPhysician profile
Thomas S Gorsche
NPI 1568416196
$5,370.56
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $898 · 2021: $2,242 · 2022: $1,565 · 2023: $269 · 2024: $97.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wardlow Enterprises | $2,193.01 | 2020-2022 | |
| Arthrex, INC. | $2,047.04 | 2021-2023 | Shoulder Implants Fibertak Knotless |
| Stryker Corporation | $402.63 | 2019-2024 | Omega, Mako, T2 Alpha |
| Depuy Synthes Sales INC. | $289.84 | 2019-2024 | Fibergraft Bg Morsels, Hammerlock |
| Wright Medical Technology, INC. | $222.85 | 2019 | |
| Zimmer Biomet Holdings, INC. | $60.84 | 2020-2021 | |
| Convatec INC. | $49.58 | 2021 | |
| Bioventus LLC | $29.04 | 2019-2021 | |
| Heraeus Medical, LLC. | $24.38 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.31 | 2019 | |
| Smith+Nephew, INC. | $17.19 | 2023 | Pico 14 |
| Pacira Pharmaceuticals Incorporated | $16.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gorsche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.